Bausch Health Cos., Inc. (BHC)
8.56
-0.17
(-1.95%)
USD |
NYSE |
Nov 19, 16:00
8.565
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cos. Price : 8.56 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 8.71 | 8.84 | 8.545 | 8.56 | 3.270M |
| Nov 18, 2026 | 8.43 | 8.845 | 8.41 | 8.73 | 7.062M |
| Nov 17, 2026 | 8.39 | 8.48 | 8.205 | 8.47 | 2.703M |
| Nov 16, 2026 | 8.34 | 8.57 | 8.34 | 8.42 | 3.819M |
| Nov 13, 2026 | 8.25 | 8.40 | 8.18 | 8.35 | 2.340M |
| Nov 12, 2026 | 8.36 | 8.43 | 8.24 | 8.25 | 2.350M |
| Nov 11, 2026 | 8.295 | 8.455 | 8.20 | 8.35 | 2.401M |
| Nov 10, 2026 | 8.39 | 8.39 | 8.155 | 8.29 | 2.451M |
| Nov 09, 2026 | 8.192 | 8.56 | 8.192 | 8.40 | 3.952M |
| Nov 06, 2026 | 7.86 | 8.195 | 7.86 | 8.18 | 3.068M |
| Nov 05, 2026 | 8.34 | 8.375 | 7.96 | 7.96 | 3.345M |
| Nov 04, 2026 | 8.28 | 8.46 | 8.225 | 8.34 | 3.530M |
| Nov 03, 2026 | 7.96 | 8.18 | 7.87 | 8.14 | 3.422M |
| Nov 02, 2026 | 8.21 | 8.345 | 7.955 | 8.02 | 4.943M |
| Oct 30, 2026 | 8.93 | 9.04 | 8.175 | 8.20 | 8.868M |
| Oct 29, 2026 | 7.66 | 9.04 | 7.58 | 8.91 | 33.78M |
| Oct 28, 2026 | 6.29 | 6.97 | 6.25 | 6.92 | 8.074M |
| Oct 27, 2026 | 6.37 | 6.37 | 6.225 | 6.31 | 1.563M |
| Oct 26, 2026 | 6.53 | 6.55 | 6.27 | 6.35 | 2.402M |
| Oct 23, 2026 | 6.44 | 6.49 | 6.201 | 6.44 | 2.427M |
| Oct 22, 2026 | 6.43 | 6.505 | 6.405 | 6.49 | 1.197M |
| Oct 21, 2026 | 6.40 | 6.515 | 6.29 | 6.45 | 2.034M |
| Oct 20, 2026 | 6.42 | 6.54 | 6.36 | 6.42 | 2.030M |
| Oct 19, 2026 | 6.27 | 6.42 | 6.25 | 6.32 | 1.355M |
| Oct 16, 2026 | 6.35 | 6.385 | 6.20 | 6.30 | 2.193M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NervGen Pharma Corp. | 1.92 |
| Milestone Pharmaceuticals, Inc. | 0.3993 |
| Appili Therapeutics, Inc. | 0.001 |
| Clearmind Medicine, Inc. | 3.04 |
| Lexaria Bioscience Corp. | 4.49 |
Price Related Metrics
| PS Ratio | 0.2893 |
| Price to Free Cash Flow | 1.788 |
| Earnings Yield | -26.77% |
| Market Cap | 3.204B |
| Operating PE Ratio | 1.065 |
| Normalized PE Ratio | 8.010 |